ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.933,76
-1,19%
S&P 500
5.205,27
0,34%
US Dollar vs BRL
5,1574
1,34%
Bitcoin
62.146,54
1,57%
Brent Oil
83,495
-0,08%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Alligator Bioscience Ab (0RK9)

  7. Alligator Bioscience Ab (0RK9) Notícias

0RK9

Alligator Bioscience Ab (0RK9)

Alligator Bioscience Ab
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:0RK9
DataHoraFonteTítuloCódigoCompanhia
01/04/202203:20PR Newswire (US)Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort CommencesLSE:0RK9Alligator Bioscience Ab
23/03/202205:07PR Newswire (US)Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kgLSE:0RK9Alligator Bioscience Ab
11/02/202204:23PR Newswire (US)Alligator Bioscience AB: Year End report January-December 2021LSE:0RK9Alligator Bioscience Ab
01/02/202205:16PR Newswire (US)Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical OfficerLSE:0RK9Alligator Bioscience Ab
19/01/202204:42PR Newswire (US)Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory BeattyLSE:0RK9Alligator Bioscience Ab
18/01/202204:19PR Newswire (US)Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects ReportedLSE:0RK9Alligator Bioscience Ab
16/12/202104:41PR Newswire (US)Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability DataLSE:0RK9Alligator Bioscience Ab
15/12/202110:37PR Newswire (US)Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal Nature CommunicationLSE:0RK9Alligator Bioscience Ab
08/11/202113:54PR Newswire (US)Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University RotterdamLSE:0RK9Alligator Bioscience Ab
08/11/202112:59PR Newswire (US)Bulletin from the extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
21/10/202103:45PR Newswire (US)Alligator Bioscience AB: Interim report January-September 2021LSE:0RK9Alligator Bioscience Ab
07/10/202103:25PR Newswire (US)Notice of extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
02/09/202107:17PR Newswire (US)Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipelineLSE:0RK9Alligator Bioscience Ab
02/09/202105:33PR Newswire (US)Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination TherapyLSE:0RK9Alligator Bioscience Ab
18/08/202103:50PR Newswire (US)Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion CorporationLSE:0RK9Alligator Bioscience Ab
16/08/202110:16PR Newswire (US)Alligator Bioscience Announces New Senior Director of Communications & Investor RelationsLSE:0RK9Alligator Bioscience Ab
30/06/202104:10PR Newswire (US)Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical dataLSE:0RK9Alligator Bioscience Ab
07/06/202103:25PR Newswire (US)Article on CD40 agonistic antibodies published in Expert Opinion on Biological TherapyLSE:0RK9Alligator Bioscience Ab
04/06/202103:20PR Newswire (US)Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017LSE:0RK9Alligator Bioscience Ab
05/05/202103:23PR Newswire (US)Alligator's mitazalimab shown to enhance cancer vaccineLSE:0RK9Alligator Bioscience Ab
04/05/202103:21PR Newswire (US)Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative fieldLSE:0RK9Alligator Bioscience Ab
27/04/202103:25PR Newswire (US)Alligator Bioscience AB: Interim report January-March 2021LSE:0RK9Alligator Bioscience Ab
22/04/202114:46PR Newswire (US)The Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bi...LSE:0RK9Alligator Bioscience Ab
15/04/202103:21PR Newswire (US)Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel ImmunotherapyLSE:0RK9Alligator Bioscience Ab
03/04/202109:02PR Newswire (US)Alligator Bioscience postpones the Annual General Meeting to June 1, 2021LSE:0RK9Alligator Bioscience Ab
18/03/202115:13PR Newswire (US)Alligator Bioscience appoints Søren Bregenholt as new CEOLSE:0RK9Alligator Bioscience Ab
18/03/202112:40PR Newswire (US)Alligator Bioscience publishes Annual Report for 2020LSE:0RK9Alligator Bioscience Ab
11/03/202104:21PR Newswire (US)Mitazalimab synergizes with chemotherapy - Alligator Bioscience presents new preclinical data at AACRLSE:0RK9Alligator Bioscience Ab
26/02/202104:27PR Newswire (US)Alligator Bioscience AB: Year-end Report January-December 2020LSE:0RK9Alligator Bioscience Ab
23/02/202112:12PR Newswire (US)Alligator Bioscience AB: Last day of trading in paid subscription shares (Sw. BTA)LSE:0RK9Alligator Bioscience Ab
 Apresentando as notícias mais relevantes sobre:LSE:0RK9

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
AZEV4
AZEVEDO PN
BOV
OIBR3
OI ON
BOV
PDTC3
Padtec ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
PRIO3
PETRORIO ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
VVEO3
CM Hospitalar ON
BOV
ENJU3
Enjoei ON
BOV
SGPS3
SPRINGS ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
JHSF3
JHSF PART ON
BOV
ENAT3
ENAUTA ON
BOV
SHOW3
TIME FOR FUN ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados